1-Hydroxybenzotriazole → HCID 10128584, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([N:11]([C@H:22]([CH2:26][CH:27]([CH3:29])[CH3:28])[C:23]([NH2:25])=[O:24])[CH2:12][C:13]2[CH:18]=[CH:17][C:16]([CH2:19][NH:20][CH3:21])=[CH:15][CH:14]=2)(=[O:10])=[O:9])=[CH:4][CH:3]=1.[OH:30]N1C2C=CC=CC=2N=N1.Cl.[CH3:41][N:42]([CH3:51])[CH2:43][CH2:44]CN=C=NCC>C(Cl)Cl>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([S:8]([N:11]([C@H:22]([CH2:26][CH:27]([CH3:29])[CH3:28])[C:23]([NH2:25])=[O:24])[CH2:12][C:13]2[CH:18]=[CH:17][C:16]([CH2:19][N:20]([C:44](=[O:30])[CH2:43][N:42]([CH3:51])[CH3:41])[CH3:21])=[CH:15][CH:14]=2)(=[O:10])=[O:9])=[CH:6][CH:7]=1Participants
Procedure
(2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methylaminomethyl-benzyl)-amino]-4-methyl-pentanoic acid amide (75 mg, 0.17 mmol), (α-dimethylamino)acetic acid (18 mg, 0.17 mmol), 1-hydroxybenzotriazole (24 mg, 0.17 mmol), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (33 mg, 0.17 mmol) were combined in 3 mL CH2Cl2 and stirred overnight. The reaction mixture was diluted with 5 mL CH2Cl2 and washed with 1 N NaOH and brine. The organic phase was dried by filtering through cotton and the solvent was removed in vacuo. Purification via preparative HPLC afforded the title compound (61 mg) in 68% yield. MS (ESI), 523.4 (M+H)+1H NMR (CDCl3) δ 8.02 (d, 2H, J=8.0), 7.71 (d, 2H, J=8.0), 7.37 (d, 2H, J=8.0), 7.28 (d, 2H, J=8.0), 6.23 (br s, 1H), 5.51 (br s, 1H), 4.46 (s, 2H), 4.70 (d, 1H, Jab=16), 4.33 (d, 1H, Jab=16), 3.25 (t, 1H, J=6.0), 2.69 (s, 3H), 2.63 (s, 2H), 2.20 (s, 6H), 1.95 (m, 1H), 1.60 (m, 2H), 0.98 (d, 3H, J=7.0), 0.94 (d, 3H, J=7.0).
Workup
- washwashed with 1 N NaOH and brine
- customThe organic phase was dried
- filtrationby filtering through cotton
- customthe solvent was removed in vacuo
- customPurification via preparative HPLC
Sources & evidence
- ORD record
- ord-646a788f86a8492598ea951cf3277ad6
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513253B2
Reaction notes
Loading…